Delays in German medtech fast-tracking ending

06/2/2013 | Clinica

The resolution of a dispute between Germany's health ministry and health care reimbursement authority has restarted the country's plan for expedited approval of medtech devices that show great promise but still lack evidence from clinical trials. The dispute between the two agencies centered on definitions of "success" and a payback scheme for industry applicants that has now been dropped.

View Full Article in:

Clinica

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Chief, Product Review Branch
FDA/Center for Biologics Evaluation and Research
Silver Spring, MD
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ